Diagenomi Ltd. is a young high-tech company that offers services and solutions in three different ar Among other DiaGenomi Ltd.
We have made an important step towards personalized medicine with the introduction of pathology supported genetic tests like CardioRISQ, which gives individuals guidelines for a healthier lifestyle and reduction of potential cardiovascular complications. As well we provide tests that enable physicians to effectively and quickly adapt treatment decisions for individual patients with the genetic ana
24/10/2019
UKC Maribor in Diagenomi
VIDEO: V UKC Maribor uspešni testi, ki zmanjšujejo število kemoterapij, a zavarovalnice nimajo posluha Študije so dokazale, da kar 46 odstotkov bolnic s klinično visokim rizikom ponovitve raka nima koristi od kemoterapije. Genomski test raka dojke zmanjšuje uporabo kemoterapije. Žal pa morajo bolnice teste plačevati same.
15/03/2019
Danes v Dnevniku je članek o moškem zdravju. Tema rak prostate. Intervju z Dr. Simonom Hawlino.
Enostaven biomarkerski urinski test SelectMDx olajša delo urologom pri diagnosticiranju raka prostate, mnogim pacientom pa prihrani neprijetno biospijo in prekomerno zdravljenje.
https://www.dnevnik.si/1042878561/magazin/zdravje/enostaven-urinski-test-pokaze-ali-gre-za-raka-prostate-ali-ne
Enostaven urinski test pokaže, ali gre za raka prostate ali ne
30/08/2017
Potrebujete kemoterapijo ali ne? Genomski test MammaPrint ter BluePrint lahko podata odgovor ali lahko varno opustite zdravljenje s kemoterapijo.
Informacije o MammaPrint testu so odslej na voljo v slovenščini na http://www.mammaprint.si/
14/05/2017
13/05/2017
Barcelona, Camp Nou connecting with best football clubs in world
22/03/2017
Many adults have insufficient knowledge about heart failure - Scienmag: Latest Science and Health News In the largest German survey on heart failure to date, investigators found that the overall awareness of heart failure has not increased over the past decade and is not at a satisfactory level. In 2..
10/02/2017
No doubt, genomics-only approach to health risk assessments are known to have its limitations. DiaGenomi overcomes limitations and integrates genotyping in a multidisciplinary framework and includes diverse patient data (i.e., biochemistry, nutritional, lifestyle, and environmental data) to provide a wholesome health risk analysis capable of detecting areas of risks and prevention/treatment strategies beyond traditional health risk assessments.
https://www.myrisq.com/cardiorisq
MyRISQ - CardioRISQ and combines the analysis of various factors that influence your health. In most cases, mutations in your genome can trigger the start of disease and poor lifestyle choices can only accelerate its progress. It is therefore important to closely monitor each group of factors and determine elements tha...
Lipid profiling coupled with nutrition and lifestyle analysis can offer so much more when analysis screens also for mutations in CV genes. CVD risks may be determined as much higher, unique nutritional needs may have to be addressed. Genetically assisted Health Risk Assessments will help determine beast treatment/prevention strategies.
25/01/2017
Genetics can make traditional Health Risk Assessment (HRA) shine!
Carefully selected genetic markers, when integrated with biometric screening, traditional HRA and lifestyle assessment can detect individual nutritional needs and future health risks.
These many times cannot be picked-up and properly addressed by only analyzing lifestyle and biometric data due to our genes interacting with other genes and the environment. These interactions may form inefficiencies in important metabolic processes involved in CV function an have great health implications that cannot be addressed only by an increase in physical activity and employment of healthy eating habits. With
help of geneticists and nutritionits best prevention or treatment approach can be chosen.
CardioRISQ assessment is such genetically assisted HRA https://www.myrisq.com/cardiorisq-for-physicians
Genetically Assisted Health Risk Assessments
The value of genetic Health Risk Assessment is increasingly recognized to:
- diagnose treatable subtypes of complex diseases that may include single gene disorders,
- facilitate prevention of cumulative…
05/12/2016
Even among those at highest genetic risk, lifestyle factors can reduce incidence by one half.
Healthy lifestyle can reduce the risk of heart disease. But what about people who have inherited gene variants known to increase risk? They can benefit from it too!
According to "ScienceDaily.com", a study led by Massachusetts General Hospital (MGH) investigators has found that, even among those at high genetic risk, following a healthy lifestyle can cut in half the probability of a heart attack or similar event. Their report is receiving early online publication in the New England Journal of Medicine to coincide with a presentation at the American Heart Association (AHA) Scientific Sessions.
Following a healthy lifestyle can greatly reduce genetic heart attack risk: Even among those at highest genetic risk, lifestyle factors can reduce incidence by one half It is well known that following a healthy lifestyle -- not smoking, avoiding excess weight and getting regular exercise -- can reduce the risk of heart disease. But what about people who have inherited gene variants known to increase risk? A study has found that, even among those at high genetic ris...
In a recent study of 47 National Hockey League (NHL) players ACL injuries in ice hockey were identified to shorten professional careers, on ice productivity, number of games played.
These findings scream for identification of ligament injury-prone athletes by physical and genetic screening and establishing pre-habilitative protocols for such individuals.
SportInjuryRISQ (https://www.myrisq.com/sportinjuryrisq)
test screens athletes for genetic predisposition and for ligament injuries, particularly ACL and AT.
http://www.ncbi.nlm.nih.gov/pubmed/26667371
Anterior Cruciate Ligament Injuries in Professional Hockey Players. - PubMed - NCBI Am J Sports Med. 2016 Feb;44(2):378-83. doi: 10.1177/0363546515616802. Epub 2015 Dec 14.
